Literature DB >> 27171243

Role of old antimicrobial agents in the management of urinary tract infection.

Noha El Sakka1, Ian M Gould1.   

Abstract

INTRODUCTION: Urinary tract infection (UTI) is a common infection worldwide. The increase in multidrug resistance together with the paucity of new antibiotics highlights the need for alternative antimicrobials for management of UTI. Among which are older antimicrobials that had been used in the past and now were stopped. AREAS COVERED: In this article, we examine the evidence in literature for the value of use of various antimicrobial agents in UTI. We conducted systematic Pubmed search and journal literature review including early research work on older agents addressed in relation to recent clinical data. Antimicrobials reviewed include temocillin, fosfomycin, mecillinam, methenamine and cycloserine. We review mechanisms of action, spectrum of activity, effect on multidrug resistance, cure rates and patient tolerance. Expert commentary: Rational use of current agents and rehabilitation of older drugs will both be needed, combined with antibiotic stewardship, in order to contain the march of antibiotic resistance.

Entities:  

Keywords:  Temocillin; cycloserine; fosfomycin; mandelic acid; mecillinam; methenamine; nitroxoline; urinary tract infection

Mesh:

Substances:

Year:  2016        PMID: 27171243     DOI: 10.1080/17512433.2016.1189325

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  8 in total

Review 1.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

2.  Identification of 8-Hydroxyquinoline Derivatives That Decrease Cystathionine Beta Synthase (CBS) Activity.

Authors:  Pierre Conan; Alice Léon; Mathilde Gourdel; Claire Rollet; Loubna Chaïr; Noéline Caroff; Nelig Le Goux; Catherine Le Jossic-Corcos; Maha Sinane; Lucile Gentile; Louise Maillebouis; Nadège Loaëc; Jennifer Martin; Marie Vilaire; Laurent Corcos; Olivier Mignen; Mikael Croyal; Cécile Voisset; Frédéric Bihel; Gaëlle Friocourt
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

3.  In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales.

Authors:  Lars Plambeck; Frieder Fuchs; Janko Sattler; Axel Hamprecht
Journal:  JAC Antimicrob Resist       Date:  2022-06-16

4.  Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.

Authors:  Margaret Ip; Christopher K Lai; Kitty S C Fung; K-Tak Wong; Chendi Zhu; Sebastien Van de Velde; Dominic N Tsang; Peter Hawkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-25       Impact factor: 3.267

5.  Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001-2015.

Authors:  Marianne Bollestad; Ingvild Vik; Nils Grude; Hege Salvesen Blix; Hanne Brekke; Morten Lindbaek
Journal:  BJGP Open       Date:  2017-10-04

6.  Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients.

Authors:  Yalda Malekzadegan; Reza Khashei; Hadi Sedigh Ebrahim-Saraie; Zahra Jahanabadi
Journal:  BMC Infect Dis       Date:  2018-11-15       Impact factor: 3.090

7.  Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.

Authors:  Liangliang Ren; Minxiao Jiang; Dingwei Xue; Huan Wang; Zeyi Lu; Lifeng Ding; Haiyun Xie; Ruyue Wang; Wenqin Luo; Li Xu; Mingchao Wang; Shicheng Yu; Sheng Cheng; Liqun Xia; Haifeng Yu; Peng Huang; Naijin Xu; Gonghui Li
Journal:  Int J Biol Sci       Date:  2022-08-08       Impact factor: 10.750

8.  Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial.

Authors:  Ingvild Vik; Marianne Bollestad; Nils Grude; Anders Bærheim; Eivind Damsgaard; Thomas Neumark; Lars Bjerrum; Gloria Cordoba; Inge Christoffer Olsen; Morten Lindbæk
Journal:  PLoS Med       Date:  2018-05-15       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.